MiREA-AC smartphone program to reduce heavy drinking and cannabis use in college students
Official title: MiREA, a mHealth Intervention to Reduce Health Disparities by Improving Access to Mandated College Students With Problematic Alcohol and Marijuana Use
Run by mHealth Systems Inc. · NCT07339150 · Data updated 2026-11-12
This project will test whether the MiREA-AC smartphone app can help college students cut down on heavy drinking and cannabis use.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 26 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | mHealth Systems Inc. Industry-sponsored |
| Locations | 2 sites (Charlotte, North Carolina and 1 other locations) |
| Status | Recruiting |
| Started | August 15, 2025 |
| Main results expected | April 30, 2026 |
| Study ends | April 30, 2026 |
| Registry record updated | January 14, 2026 |
| Trial ID | NCT07339150 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
College students who have consumed alcohol in the past 90 days (including those mandated for alcohol education) and who want to reduce alcohol or cannabis use are the intended participants.
✕Probably not a fit
Students who do not use alcohol or cannabis, are not enrolled at a participating college, or who require intensive inpatient treatment for a substance use disorder are unlikely to benefit from this app-based intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
MiREA-AC is an expanded smartphone intervention that adds cannabis content, an improved user interface, and administrative-reporting information to an evidence-based alcohol app. The program is delivered as nine modular features over a two-week period (intro video, daily log, virtual coach, texts, personalized feedback, gaming/learning, strategies, and where to go). The study starts with alpha theater and field testing at two campuses (n=10) followed by a multisite pilot feasibility trial across six U.S. campuses (n=50) to gather usability, feasibility, and preliminary efficacy data. Results will inform refinement, commercialization planning, and broader dissemination strategies.
Why it matters
Potential benefit: If successful, MiREA-AC could provide colleges with an accessible, scalable app that helps students reduce heavy episodic drinking and cannabis misuse and find appropriate resources.
How similar studies have gone: Previous MiREA-A work showed effectiveness for alcohol use, but adding integrated cannabis content and administrative modules in MiREA-AC is a novel expansion with limited prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * College student, alcohol consumption in past 90 days Exclusion Criteria: * non-college student, no alcohol use in the past 90 days
Where it's running
-
University of North Carolina, Charlotte
Charlotte, North Carolina, United States Recruiting -
University of South Carolina
Columbia, South Carolina, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PSP Alcohol Reset Course for Public Safety Personnel
A self-guided online program tests whether a digital cognitive-behavioral course can help public safety personnel reduce risky drinking and improve well-being.
-
Digital AI coaching and weekly texts to cut risky drinking in the ED
A digital AI counseling tool plus weekly SMS reminders aims to help adults with alcohol misuse seen in the emergency department see if their drinking can be reduced.
-
Does a CDT level at ICU admission predict short-term outcomes in critically ill adults?
This study tests whether high carbohydrate-deficient transferrin levels at ICU admission can predict worse short-term outcomes for adults with critical illness from emergency department admissions.
-
PEth-boosted brief intervention for alcohol use in people with HIV
In this study, people with HIV who drink at risky levels are randomized to receive standard MOH counseling with or without a PEth blood test result to see if linking test results to counseling helps reduce drinking.
-
Apremilast for reducing alcohol craving in adults with alcohol use disorder
This study will try two daily doses of apremilast versus placebo to see if they reduce alcohol craving in adults with moderate to severe alcohol use disorder.
-
Adaptive actions during online cognitive behavioural therapy for alcohol misuse
This project will see if doing helpful daily actions more often is linked to reduced drinking in adults in Canada taking an online cognitive behavioural therapy course for alcohol misuse.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.